Cargando…
The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study
BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic d...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340041/ https://www.ncbi.nlm.nih.gov/pubmed/28264719 http://dx.doi.org/10.1186/s13023-017-0595-3 |
_version_ | 1782512772836229120 |
---|---|
author | van Egmond, Martje E. Weijenberg, Amerins van Rijn, Margreet E. Elting, Jan Willem J. Gelauff, Jeannette M. Zutt, Rodi Sival, Deborah A. Lambrechts, Roald A. Tijssen, Marina A. J. Brouwer, Oebele F. de Koning, Tom J. |
author_facet | van Egmond, Martje E. Weijenberg, Amerins van Rijn, Margreet E. Elting, Jan Willem J. Gelauff, Jeannette M. Zutt, Rodi Sival, Deborah A. Lambrechts, Roald A. Tijssen, Marina A. J. Brouwer, Oebele F. de Koning, Tom J. |
author_sort | van Egmond, Martje E. |
collection | PubMed |
description | BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic drugs is disappointingly limited in North Sea Progressive Myoclonus Epilepsy. The ketogenic diet and the less restrictive modified Atkins diet have been proven to be effective in other drug-resistant epilepsy syndromes, including those with myoclonic seizures. Our aim was to evaluate the efficacy of the modified Atkins diet in patients with North Sea Progressive Myoclonus Epilepsy. RESULTS: Four North Sea Progressive Myoclonus Epilepsy patients (aged 7–20 years) participated in an observational, prospective, open-label study on the efficacy of the modified Atkins diet. Several clinical parameters were assessed at baseline and again after participants had been on the diet for 3 months. The primary outcome measure was health-related quality of life, with seizure frequency and blinded rated myoclonus severity as secondary outcome measures. Ketosis was achieved within 2 weeks and all patients completed the 3 months on the modified Atkins diet. The diet was well tolerated by all four patients. Health-related quality of life improved considerably in one patient and showed sustained improvement during long-term follow-up, despite the progressive nature of the disorder. Health-related quality of life remained broadly unchanged in the other three patients and they did not continue the diet. Seizure frequency remained stable and blinded rating of their myoclonus showed improvement, albeit modest, in all patients. CONCLUSIONS: This observational, prospective study shows that some North Sea Progressive Myoclonus Epilepsy patients may benefit from the modified Atkins diet with sustained health-related quality of life improvement. Not all our patients continued on the diet, but nonetheless we show that the modified Atkins diet might be considered as a possible treatment in this devastating disorder. |
format | Online Article Text |
id | pubmed-5340041 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53400412017-03-10 The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study van Egmond, Martje E. Weijenberg, Amerins van Rijn, Margreet E. Elting, Jan Willem J. Gelauff, Jeannette M. Zutt, Rodi Sival, Deborah A. Lambrechts, Roald A. Tijssen, Marina A. J. Brouwer, Oebele F. de Koning, Tom J. Orphanet J Rare Dis Research BACKGROUND: North Sea Progressive Myoclonus Epilepsy is a rare and severe disorder caused by mutations in the GOSR2 gene. It is clinically characterized by progressive myoclonus, seizures, early-onset ataxia and areflexia. As in other progressive myoclonus epilepsies, the efficacy of antiepileptic drugs is disappointingly limited in North Sea Progressive Myoclonus Epilepsy. The ketogenic diet and the less restrictive modified Atkins diet have been proven to be effective in other drug-resistant epilepsy syndromes, including those with myoclonic seizures. Our aim was to evaluate the efficacy of the modified Atkins diet in patients with North Sea Progressive Myoclonus Epilepsy. RESULTS: Four North Sea Progressive Myoclonus Epilepsy patients (aged 7–20 years) participated in an observational, prospective, open-label study on the efficacy of the modified Atkins diet. Several clinical parameters were assessed at baseline and again after participants had been on the diet for 3 months. The primary outcome measure was health-related quality of life, with seizure frequency and blinded rated myoclonus severity as secondary outcome measures. Ketosis was achieved within 2 weeks and all patients completed the 3 months on the modified Atkins diet. The diet was well tolerated by all four patients. Health-related quality of life improved considerably in one patient and showed sustained improvement during long-term follow-up, despite the progressive nature of the disorder. Health-related quality of life remained broadly unchanged in the other three patients and they did not continue the diet. Seizure frequency remained stable and blinded rating of their myoclonus showed improvement, albeit modest, in all patients. CONCLUSIONS: This observational, prospective study shows that some North Sea Progressive Myoclonus Epilepsy patients may benefit from the modified Atkins diet with sustained health-related quality of life improvement. Not all our patients continued on the diet, but nonetheless we show that the modified Atkins diet might be considered as a possible treatment in this devastating disorder. BioMed Central 2017-03-07 /pmc/articles/PMC5340041/ /pubmed/28264719 http://dx.doi.org/10.1186/s13023-017-0595-3 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research van Egmond, Martje E. Weijenberg, Amerins van Rijn, Margreet E. Elting, Jan Willem J. Gelauff, Jeannette M. Zutt, Rodi Sival, Deborah A. Lambrechts, Roald A. Tijssen, Marina A. J. Brouwer, Oebele F. de Koning, Tom J. The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title | The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title_full | The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title_fullStr | The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title_full_unstemmed | The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title_short | The efficacy of the modified Atkins diet in North Sea Progressive Myoclonus Epilepsy: an observational prospective open-label study |
title_sort | efficacy of the modified atkins diet in north sea progressive myoclonus epilepsy: an observational prospective open-label study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340041/ https://www.ncbi.nlm.nih.gov/pubmed/28264719 http://dx.doi.org/10.1186/s13023-017-0595-3 |
work_keys_str_mv | AT vanegmondmartjee theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT weijenbergamerins theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT vanrijnmargreete theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT eltingjanwillemj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT gelauffjeannettem theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT zuttrodi theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT sivaldeboraha theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT lambrechtsroalda theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT tijssenmarinaaj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT brouweroebelef theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT dekoningtomj theefficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT vanegmondmartjee efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT weijenbergamerins efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT vanrijnmargreete efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT eltingjanwillemj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT gelauffjeannettem efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT zuttrodi efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT sivaldeboraha efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT lambrechtsroalda efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT tijssenmarinaaj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT brouweroebelef efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy AT dekoningtomj efficacyofthemodifiedatkinsdietinnorthseaprogressivemyoclonusepilepsyanobservationalprospectiveopenlabelstudy |